Doula Support

The Bohren Cochrane review is the strongest evidence in the doula literature, and Cochrane is the strongest type of evidence in medicine generally. The team pooled data from 26 randomized controlled trials covering 15,800 women across multiple countries.

The results showed continuous one-on-one labor support reduced cesareans by 25 percent, reduced instrumental deliveries by 10 percent, reduced low Apgar scores by 38 percent, increased spontaneous vaginal births by 8 percent, and shortened labor by 41 minutes on average. Women reported 35 percent fewer negative birth experiences when they had continuous support. The review documented zero harms across all 26 trials.

The effect was strongest when the support came from someone independent of the hospital staff and the woman's social network. That last point matters. A doula is not the same as the partner being present, and the evidence is clearer for the doula role than for additional social support generally.

The Falconi team published a 2022 study in Lancet eClinicalMedicine examining doulas and postpartum mental health. Women who had doula support during pregnancy and labor showed 57.5 percent lower odds of postpartum depression or anxiety. For the women who specifically had a doula present during labor itself, the reduction in PPD/PPA odds was 64.7 percent.

The cesarean rate among women with doula care was 18.7 percent, compared with 30.7 percent without. The study used propensity-score matching to control for the kinds of women who tend to choose doula care, which addresses the obvious selection-bias concern. The results held after adjustment.

Karwa and colleagues published the first large-scale study of virtual doula care in Obstetrics & Gynecology in 2024, analyzing roughly 9,000 users of the Maven Clinic digital platform. Users who completed two or more virtual doula appointments had a 20 percent reduction in odds of cesarean (aOR 0.80) compared with matched controls.

The effect was substantially stronger in Black users with two or more visits, who showed a 68 percent reduction in cesarean odds (aOR 0.32). The study also found a dose-response relationship: more sessions correlated with larger effect sizes, which is the kind of pattern that strengthens causal inference. The results suggest virtual doula care can deliver comparable benefits to in-person care, which has practical implications for access, especially in rural areas where in-person doulas are not available.

ACOG, the American College of Obstetricians and Gynecologists, issued Committee Opinion 766 in 2019 endorsing doula care. The specific language: doula support is "one of the most effective tools to improve labor and delivery outcomes." This endorsement matters because ACOG is the professional body that sets the practice standard for the majority of US obstetricians.

The opinion includes the evidence base from the Cochrane review and recommends that women have access to continuous labor support. Implementation has been slow. Most US hospitals do not yet make doulas part of standard care, and most US insurance plans do not cover doula services, though Medicaid coverage is expanding rapidly.

Evidence Based Birth pulled together the doula literature into a single overview, including the satisfaction data that the clinical studies do not always foreground. Across the studies they reviewed, women with doula support reported 92 percent satisfaction with their birth experience.

The effect was strongest when the doula was trained and independent of both hospital staff and the woman's family. One question the literature addresses directly is whether a doula displaces the partner's role. The answer is the opposite.

Partners of women who had doulas reported feeling more confident, more useful, and more present during the birth. The doula handles the continuous emotional and physical support, which frees the partner to be the partner rather than trying to fill both roles.

The Lemon team published a study in the American Journal of Obstetrics & Gynecology (epub August 2024, print April 2025) that quantified the benefits of doula care across the full maternity continuum using propensity-score matching. The matching approach addresses the obvious concern that women who choose doula care may differ in other ways from women who do not.

After adjustment, doula care was associated with significantly more VBACs (15.6 to 34.2 additional VBACs per 100 patients), more postpartum office visit attendance, higher exclusive breastfeeding (7.9 to 11.4 more per 100), and fewer preterm deliveries (3.8 to 4.0 fewer per 100). The paper strengthens the case that the doula effect extends well beyond the labor itself, into postpartum recovery, breastfeeding establishment, and the prevention of preterm birth, which is one of the harder outcomes to move in maternal health.

Kozhimannil's 2013 paper in the American Journal of Public Health is the foundational US study on doulas in publicly funded care. The team analyzed Medicaid births and compared outcomes for women who received doula support with those who did not.

Cesarean rates were 22.3 percent for the doula group versus 31.5 percent for the no-doula group. Breastfeeding initiation was 97.9 percent with doula versus 80.8 percent without.

The effect on Black women's breastfeeding was particularly large, 92.7 percent versus 70.3 percent, which closed nearly the entire racial gap on that outcome. The team calculated that for every nine women receiving doula support, one cesarean was prevented. The paper became the evidence base for subsequent Medicaid policy expansion.

The follow-up 2016 Kozhimannil paper in Birth ran the economic analysis. If doula care were available to all US Medicaid beneficiaries, the projected annual savings would be 58.4 million dollars, primarily through reduced cesarean rates and reduced NICU admissions. The paper was instrumental in driving state-level Medicaid policy.

In 2020, two US states covered doula care under Medicaid. By 2026, 26 states plus DC do.

Washington pays up to 3,500 dollars per Medicaid client for doula services. The expansion has been one of the fastest policy shifts in US maternal health, driven directly by this cost-effectiveness evidence combined with the clinical outcome data.

The CDC tracks vaginal birth after cesarean (VBAC) rates through Data Brief No. 359, published in March 2020 covering 2016 to 2018. The national VBAC rate rose from 12.4 percent in 2016 to 12.8 percent in 2017 and 13.3 percent in 2018.

The rate increased in 17 states and declined in only 1. All race and Hispanic-origin groups had higher VBAC rates in 2018 than in 2016, with the single exception of non-Hispanic Native Hawaiian or Other Pacific Islander women.

VBAC success rates when attempted run around 70 percent overall in the broader literature, with home birth registries (MANA) reporting around 87 percent. The numbers matter because the conventional approach in the US for the last several decades has been "once a cesarean, always a cesarean," which is not what the evidence supports. ACOG updated its guidelines years ago to support VBAC for appropriate candidates, but many hospitals still refuse to offer it, often citing malpractice insurance constraints rather than clinical evidence.